The Board
(i) Noted the overarching dashboard and detail provided on specific indicators, and areas where new data was available
(ii) Commented on issues and actions being taken to improve or sustain good performance, and the work that of the sub groups;
(iii) Agreed that Cancer treatment outcomes should be a subject for more in-depth discussion at a future meeting.